Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials.
Saved in:
| Title: | Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials. |
|---|---|
| Authors: | Pang J; Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China., Ding N; Department of Clinical Laboratory, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, China., Liu X; Department of General Surgery, The First People's Hospital of Xiangtan, Xiangtan, China., He X; Department of Breast and Thyroid Surgery, The First People's Hospital of Chenzhou, Chenzhou, China., Zhou W; Department of Breast Surgery, The Affiliated Zhuzhou Hospital of Xiangya School of Medicine, Zhuzhou, China., Xie H; Department of Breast and Thyroid Surgery, The Third People's Hospital of Chenzhou, Chenzhou, China., Feng J; Department of Breast and Thyroid Surgery, The First People's Hospital of Huaihua, Huaihua, China., Li Y; Changsha Medical University, Changsha, Hunan, China., He Y; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China., Wang S; Department of Breast Surgery, Multidisciplinary Breast Cancer Center, Xiangya Hospital, Central South University, Changsha, China., Xiao Z; Department of Breast Surgery, General Surgery, Clinical Research Center for Breast Cancer in Hunan Province, National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Xiangya Hospital, Central South University, Xiangya, China. zhixiao@csu.edu.cn. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2025 Feb; Vol. 32 (2), pp. 750-759. Date of Electronic Publication: 2024 Nov 20. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39565489 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pang+J%22">Pang J</searchLink>; Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Ding+N%22">Ding N</searchLink>; Department of Clinical Laboratory, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Department of General Surgery, The First People's Hospital of Xiangtan, Xiangtan, China.<br /><searchLink fieldCode="AU" term="%22He+X%22">He X</searchLink>; Department of Breast and Thyroid Surgery, The First People's Hospital of Chenzhou, Chenzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhou+W%22">Zhou W</searchLink>; Department of Breast Surgery, The Affiliated Zhuzhou Hospital of Xiangya School of Medicine, Zhuzhou, China.<br /><searchLink fieldCode="AU" term="%22Xie+H%22">Xie H</searchLink>; Department of Breast and Thyroid Surgery, The Third People's Hospital of Chenzhou, Chenzhou, China.<br /><searchLink fieldCode="AU" term="%22Feng+J%22">Feng J</searchLink>; Department of Breast and Thyroid Surgery, The First People's Hospital of Huaihua, Huaihua, China.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Changsha Medical University, Changsha, Hunan, China.<br /><searchLink fieldCode="AU" term="%22He+Y%22">He Y</searchLink>; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Department of Breast Surgery, Multidisciplinary Breast Cancer Center, Xiangya Hospital, Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Xiao+Z%22">Xiao Z</searchLink>; Department of Breast Surgery, General Surgery, Clinical Research Center for Breast Cancer in Hunan Province, National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Xiangya Hospital, Central South University, Xiangya, China. zhixiao@csu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229420840%22">Annals of surgical oncology</searchLink> [Ann Surg Oncol] 2025 Feb; Vol. 32 (2), pp. 750-759. <i>Date of Electronic Publication: </i>2024 Nov 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9420840 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1534-4681 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210689265%22">10689265 </searchLink><i>NLM ISO Abbreviation: </i>Ann Surg Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39565489 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1245/s10434-024-16454-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 750 Titles: – TitleFull: Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pang J – PersonEntity: Name: NameFull: Ding N – PersonEntity: Name: NameFull: Liu X – PersonEntity: Name: NameFull: He X – PersonEntity: Name: NameFull: Zhou W – PersonEntity: Name: NameFull: Xie H – PersonEntity: Name: NameFull: Feng J – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: He Y – PersonEntity: Name: NameFull: Wang S – PersonEntity: Name: NameFull: Xiao Z IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2025 Feb Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1534-4681 Numbering: – Type: volume Value: 32 – Type: issue Value: 2 Titles: – TitleFull: Annals of surgical oncology Type: main |
| ResultId | 1 |